Ayrton Capital LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 1:44 pm Sale | 2024-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 657,614 6.200% | -15,296 (-2.27%) | Filing |
| 2024-11-14 5:17 pm Purchase | 2024-09-30 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 672,910 6.500% | 428,619 (+175.45%) | Filing |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Ayrton Capital LLC | 244,291 9.900% | 244,291 (New Position) | Filing |